A Phase 3 interventional study of Somatropin in Endocrine System Diseases, sponsored by Pfizer. Completed at 18 sites in France. Open to participants aged 11 Years to 13 Years. Per ClinicalTrials.gov, last updated 2012-12-19.
Sponsored by Pfizer · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To show an increase in annual growth rate 3 years after Visit 2. Annual growth rate in standard deviation (SD) after 3 years will be compared to growth rate before the start of GH treatment.
322 studies on the registry are indexed under Endocrine System Diseases; 51 are open to participants now.
This study's enrollment of 46 is below the median of 69 across 221 interventional studies indexed under Endocrine System Diseases.
Browse Endocrine System Diseases studies →Pfizer is the lead sponsor of 3,337 studies on the registry; 146 are open to participants now.
Of its 601 completed or terminated interventional studies of FDA-regulated products, 392 (65%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Somatropin
Adapted dosage based on IGF 1 level and weight Form: liquid; Dosage and Frequency: from 0.0033mg/kg/day to 0.0067 mg/kg/day; Duration: 3 years
Change From Baseline in Annual Growth Rate Standard Deviation Score (SDS) for Chronological Age (CA) at Month 36 in Intent-to-Treat (ITT) Population
Change in annual growth rate (AGR) standard deviation score (SDS) for chronological age (CA) derived by subtracting AGR SDS CA at baseline from each time point (Yx) value. AGR at Yx= (height Yx-height Y\[x-1\])/(\[date of Yx-date of Y{x-1}\]/365.25). AGR as SDS calculated using Sempe reference means and standard deviations (SD) for growth rate. AGR SDS CA (for both baseline and Yx)= (AGR-reference mean for growth rate CA)/reference SD for growth rate CA. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar participant was to reference population.
Time frame: Baseline, Month 36
Change From Baseline in Annual Growth Rate Standard Deviation Score (SDS) for Chronological Age (CA) at Month 36 in Per-Protocol (PP) Population
Change in annual growth rate (AGR) standard deviation score (SDS) for chronological age (CA) derived by subtracting AGR SDS CA at baseline from each time point (Yx) value. AGR at Yx= (height Yx-height Y\[x-1\])/(\[date of Yx-date of Y{x-1}\]/365.25). AGR as SDS calculated using Sempe reference means and standard deviations (SD) for growth rate. AGR SDS CA (for both baseline and Yx)= (AGR-reference mean for growth rate CA)/reference SD for growth rate CA. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar participant was to reference population.
Time frame: Baseline, Month 36
Change From Baseline in Annual Growth Rate at Month 12, Month 24 and Month 36 in ITT Population
Change in AGR at Yx was derived by subtracting AGR at baseline from Yx value. Annual growth rate was calculated each year and rescaled to 1 year if the interval between Yx and Y\[x-1\] was not 365 days, as long as a participant remained in the study. AGR at Yx was calculated using the previous height measurements (Y\[x-1\]) and height recorded at Yx (AGR Yx = \[height Yx-height Y{x-1}\] / (\[date of Yx - date of Y{x-1}\] /365.25).
Time frame: Baseline, Month 12, Month 24, Month 36
Change From Baseline in Annual Growth Rate at Month 12, Month 24, Month 36 in PP Population
Change in AGR at Yx was derived by subtracting AGR at baseline from Yx value. Annual growth rate was calculated each year and rescaled to 1 year if the interval between Yx and Y\[x-1\] was not 365 days, as long as a participant remained in the study. AGR at Yx was calculated using the previous height measurements (Y\[x-1\]) and height recorded at Yx (AGR Yx = \[height Yx-height Y{x-1}\] / (\[date of Yx - date of Y{x-1}\] /365.25).
Time frame: Baseline, Month 12, Month 24, Month 36
Height
Height was measured using a wall mounted device (example, Harpenden stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded.
Time frame: Baseline, Month 12, Month 24, Month 36
Change From Baseline in Height at Month 12, Month 24 and Month 36
Height was measured using a wall mounted device (example, Harpenden stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded.
Time frame: Baseline, Month 12, Month 24, Month 36
Mean Height Standard Deviation Score (SDS) for Chronological Age (CA)
Height was measured using a wall mounted device (example, Harpenden stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded. Height SDS CA Yx = (height Yx - reference mean for CA Yx) / reference SD for CA Yx. Height in SDS was calculated using Sempe reference means and SD for height. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar the participant was to the reference population.
Time frame: Baseline, Month 12, Month 24, Month 36
Change From Baseline in Height Standard Deviation Score (SDS) for Chronological Age (CA) at Month 12, Month 24 and Month 36
Change in height SDS CA was derived by subtracting height SDS CA at baseline from Yx value. Height SDS CA (for both baseline and Yx) = (height - reference mean for CA)/reference SD for CA. Height in SDS was calculated using Sempe reference means and SD for height. CA calculated as integer (Date of height measurement - Date of birth)/365.25\*12. SDS indicates how similar the participant was to the reference population.
Time frame: Baseline, Month 12, Month 24, Month 36
Mean Height Standard Deviation Score (SDS) for Bone Age (BA)
Height SDS BA Yx = (height Yx - reference mean for BA Yx) / reference SD for BA Yx. Height in SDS was calculated using Sempe reference means and SD for height. BA was estimated locally using an X-ray from the left wrist and hand. SDS indicates how similar the participant was to the reference population.
Time frame: Baseline, Month 12, Month 24, Month 36
Change From Baseline in Height Standard Deviation Score (SDS) for Bone Age (BA) at Month 12, Month 24 and Month 36
Change in height SDS BA was derived by subtracting height SDS BA at baseline from Yx value. Height SDS BA (for both baseline and Yx) = (height-reference mean for BA)/reference SD for BA. Height in SDS was calculated using Sempe reference means and SD for height. BA was estimated locally using an X-ray from the left wrist and hand. SDS indicates how similar the participant was to the reference population.
Time frame: Baseline, Month 12, Month 24, Month 36
Change From Baseline in Annual Growth Rate Standard Deviation Score (SDS) for Chronological Age (CA) at Month 12 and Month 24 in ITT Population
Change in AGR SDS for CA derived by subtracting AGR SDS CA at baseline from Yx value. AGR at Yx= (height Yx-height Y\[x-1\])/(\[date of Yx-date of Y{x-1}\]/365.25). AGR as SDS calculated using Sempe reference means and standard deviations (SD) for growth rate. AGR SDS CA (for both baseline and Yx)= (AGR-reference mean for growth rate CA)/reference SD for growth rate CA. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar participant was to reference population.
Time frame: Baseline, Month 12, Month 24
Change From Baseline in Annual Growth Rate Standard Deviation Score (SDS) for Chronological Age (CA) at Month 12 and Month 24 in PP Population
Change in annual growth rate (AGR) standard deviation score (SDS) for chronological age (CA) derived by subtracting AGR SDS CA at baseline from each time point (Yx) value. AGR at Yx= (height Yx-height Y\[x-1\])/(\[date of Yx-date of Y{x-1}\]/365.25). AGR as SDS calculated using Sempe reference means and standard deviations (SD) for growth rate. AGR SDS CA (for both baseline and Yx)= (AGR-reference mean for growth rate CA)/reference SD for growth rate CA. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar participant was to reference population.
Time frame: Baseline, Month 12, Month 24
Mean Growth Rate Standard Deviation Score (SDS) for Bone Age (BA)
AGR at Yx was derived by subtracting AGR at baseline from Yx value. AGR was calculated each year and rescaled to 1 year if the interval between Yx and Y\[x-1\] was not 365 days, as long as a participant remained in the study. AGR at Yx = \[height Yx-height Y{x-1}\] / (\[date of Yx - date of Y{x-1}\] /365.25). GR in SDS was calculated using Sempe reference means and SD for growth. BA was estimated locally using an X-ray from the left wrist and hand. SDS indicates how similar the participant was to the reference population.
Time frame: Month 12, Month 24, Month 36
Body Mass Index (BMI)
BMI was used to measure body fat based on height and weight. It was calculated as body weight (kilogram) divided by the height (meter) squared.
Time frame: Baseline, Month 12, Month 24, Month 36
Change From Baseline in Body Mass Index (BMI) at Month 12, Month 24 and Month 36
BMI was used to measure body fat based on height and weight. It was calculated as body weight (kilogram) divided by the height (meter) squared.
Time frame: Baseline, Month 12, Month 24, Month 36
Change From Baseline in Bone Age (BA) at Month 12, Month 24 and Month 36
BA was estimated locally using an X-ray from the left wrist and hand.
Time frame: Baseline, Month 12, Month 24, Month 36
Ratio of Bone Age (BA) to Chronological Age (CA)
BA was estimated locally using an X-ray from the left wrist and hand. CA at the date of corresponding X-ray (Date of X-ray - Date of birth)/365.25. Ratio of BA/CA at each annual study visit was calculated.
Time frame: Baseline, Month 12, Month 24, Month 36
| Milestone | Genotonorm |
|---|---|
| Started | 46 |
| Completed | 31 |
| Not completed | 15 |
| Withdrew: Lack of efficacy | 3 |
| Withdrew: Withdrawal by subject | 5 |
| Withdrew: Other | 7 |
Change in annual growth rate (AGR) standard deviation score (SDS) for chronological age (CA) derived by subtracting AGR SDS CA at baseline from each time point (Yx) value. AGR at Yx= (height Yx-height Y\[x-1\])/(\[date of Yx-date of Y{x-1}\]/365.25). AGR as SDS calculated using Sempe reference means and standard deviations (SD) for growth rate. AGR SDS CA (for both baseline and Yx)= (AGR-reference mean for growth rate CA)/reference SD for growth rate CA. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar participant was to reference population.
| SDS | Genotonorm |
|---|---|
| Baseline (n = 42) | -1.29 ± 1.79 |
| Change at Month 36 (n = 26) | 2.36 ± 1.98 |
Change in annual growth rate (AGR) standard deviation score (SDS) for chronological age (CA) derived by subtracting AGR SDS CA at baseline from each time point (Yx) value. AGR at Yx= (height Yx-height Y\[x-1\])/(\[date of Yx-date of Y{x-1}\]/365.25). AGR as SDS calculated using Sempe reference means and standard deviations (SD) for growth rate. AGR SDS CA (for both baseline and Yx)= (AGR-reference mean for growth rate CA)/reference SD for growth rate CA. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar participant was to reference population.
| SDS | Genotonorm |
|---|---|
| Baseline (n = 14) | -1.98 ± 1.06 |
| Change at Month 36 (n = 12) | 2.70 ± 2.02 |
Change in AGR at Yx was derived by subtracting AGR at baseline from Yx value. Annual growth rate was calculated each year and rescaled to 1 year if the interval between Yx and Y\[x-1\] was not 365 days, as long as a participant remained in the study. AGR at Yx was calculated using the previous height measurements (Y\[x-1\]) and height recorded at Yx (AGR Yx = \[height Yx-height Y{x-1}\] / (\[date of Yx - date of Y{x-1}\] /365.25).
| centimeter per year (cm/year) | Genotonorm |
|---|---|
| Baseline (n = 42) | 4.5 ± 1.8 |
| Change at Month 12 (n = 36) | 3.3 ± 2.9 |
| Change at Month 24 (n = 35) | 2.5 ± 2.7 |
| Change at Month 36 (n = 26) | 2.0 ± 2.0 |
Change in AGR at Yx was derived by subtracting AGR at baseline from Yx value. Annual growth rate was calculated each year and rescaled to 1 year if the interval between Yx and Y\[x-1\] was not 365 days, as long as a participant remained in the study. AGR at Yx was calculated using the previous height measurements (Y\[x-1\]) and height recorded at Yx (AGR Yx = \[height Yx-height Y{x-1}\] / (\[date of Yx - date of Y{x-1}\] /365.25).
| cm/year | Genotonorm |
|---|---|
| Baseline (n = 14) | 4.0 ± 1.0 |
| Change at Month 12 (n = 14) | 4.0 ± 1.0 |
| Change at Month 24 (n = 14) | 2.5 ± 1.3 |
| Change at Month 36 (n = 12) | 1.8 ± 1.1 |
Height was measured using a wall mounted device (example, Harpenden stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded.
| cm | Genotonorm |
|---|---|
| Baseline (n = 44) | 123.9 ± 17.3 |
| Month 12 (n = 39) | 130.3 ± 17.5 |
| Month 24 (n = 39) | 137.8 ± 16.9 |
| Month 36 (n = 27) | 143.5 ± 15.8 |
Height was measured using a wall mounted device (example, Harpenden stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded.
| cm | Genotonorm |
|---|---|
| Change at Month 12 (n = 39) | 7.7 ± 2.1 |
| Change at Month 24 (n = 39) | 14.9 ± 3.4 |
| Change at Month 36 (n = 27) | 22.3 ± 3.7 |
Height was measured using a wall mounted device (example, Harpenden stadiometer). The standing height of the participant was measured two times and the mean of these measurements was recorded. Height SDS CA Yx = (height Yx - reference mean for CA Yx) / reference SD for CA Yx. Height in SDS was calculated using Sempe reference means and SD for height. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar the participant was to the reference population.
| SDS | Genotonorm |
|---|---|
| Baseline (n = 44) | -2.84 ± 0.91 |
| Month 12 (n = 39) | -2.42 ± 0.98 |
| Month 24 (n = 39) | -2.09 ± 1.08 |
| Month 36 (n = 27) | -1.72 ± 0.96 |
Change in height SDS CA was derived by subtracting height SDS CA at baseline from Yx value. Height SDS CA (for both baseline and Yx) = (height - reference mean for CA)/reference SD for CA. Height in SDS was calculated using Sempe reference means and SD for height. CA calculated as integer (Date of height measurement - Date of birth)/365.25\*12. SDS indicates how similar the participant was to the reference population.
| SDS | Genotonorm |
|---|---|
| Change at Month 12 (n = 39) | 0.41 ± 0.42 |
| Change at Month 24 (n = 39) | 0.81 ± 0.60 |
| Change at Month 36 (n = 27) | 1.03 ± 0.62 |
Height SDS BA Yx = (height Yx - reference mean for BA Yx) / reference SD for BA Yx. Height in SDS was calculated using Sempe reference means and SD for height. BA was estimated locally using an X-ray from the left wrist and hand. SDS indicates how similar the participant was to the reference population.
| SDS | Genotonorm |
|---|---|
| Baseline (n = 35) | -0.71 ± 1.52 |
| Month 12 (n = 32) | -0.55 ± 1.68 |
| Month 24 (n = 32) | -0.49 ± 1.77 |
| Month 36 (n = 20) | -0.30 ± 1.46 |
Change in height SDS BA was derived by subtracting height SDS BA at baseline from Yx value. Height SDS BA (for both baseline and Yx) = (height-reference mean for BA)/reference SD for BA. Height in SDS was calculated using Sempe reference means and SD for height. BA was estimated locally using an X-ray from the left wrist and hand. SDS indicates how similar the participant was to the reference population.
| SDS | Genotonorm |
|---|---|
| Change at Month 12 (n = 28) | -0.05 ± 1.04 |
| Change at Month 24 (n = 27) | 0.06 ± 1.36 |
| Change at Month 36 (n = 17) | 0.05 ± 1.32 |
Change in AGR SDS for CA derived by subtracting AGR SDS CA at baseline from Yx value. AGR at Yx= (height Yx-height Y\[x-1\])/(\[date of Yx-date of Y{x-1}\]/365.25). AGR as SDS calculated using Sempe reference means and standard deviations (SD) for growth rate. AGR SDS CA (for both baseline and Yx)= (AGR-reference mean for growth rate CA)/reference SD for growth rate CA. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar participant was to reference population.
| SDS | Genotonorm |
|---|---|
| Change at Month 12 (n = 36) | 3.23 ± 2.66 |
| Change at Month 24 (n = 35) | 2.62 ± 2.05 |
Change in annual growth rate (AGR) standard deviation score (SDS) for chronological age (CA) derived by subtracting AGR SDS CA at baseline from each time point (Yx) value. AGR at Yx= (height Yx-height Y\[x-1\])/(\[date of Yx-date of Y{x-1}\]/365.25). AGR as SDS calculated using Sempe reference means and standard deviations (SD) for growth rate. AGR SDS CA (for both baseline and Yx)= (AGR-reference mean for growth rate CA)/reference SD for growth rate CA. CA calculated as integer (Date of height measurement-Date of birth)/365.25\*12. SDS indicates how similar participant was to reference population.
| SDS | Genotonorm |
|---|---|
| Change at Month 12 (n = 14) | 4.40 ± 2.12 |
| Change at Month 24 (n = 14) | 2.97 ± 1.68 |
AGR at Yx was derived by subtracting AGR at baseline from Yx value. AGR was calculated each year and rescaled to 1 year if the interval between Yx and Y\[x-1\] was not 365 days, as long as a participant remained in the study. AGR at Yx = \[height Yx-height Y{x-1}\] / (\[date of Yx - date of Y{x-1}\] /365.25). GR in SDS was calculated using Sempe reference means and SD for growth. BA was estimated locally using an X-ray from the left wrist and hand. SDS indicates how similar the participant was to the reference population.
| SDS | Genotonorm |
|---|---|
| Month 12 (n = 28) | 1.06 ± 1.57 |
| Month 24 (n = 25) | 0.46 ± 1.15 |
| Month 36 (n = 19) | -0.01 ± 1.19 |
BMI was used to measure body fat based on height and weight. It was calculated as body weight (kilogram) divided by the height (meter) squared.
| kilogram per square meter (kg/m^2) | Genotonorm |
|---|---|
| Baseline (n = 44) | 16.57 ± 2.37 |
| Month 12 (n = 39) | 16.96 ± 2.64 |
| Month 24 (n = 39) | 17.59 ± 2.69 |
| Month 36 (n = 27) | 17.67 ± 2.08 |
BMI was used to measure body fat based on height and weight. It was calculated as body weight (kilogram) divided by the height (meter) squared.
| kg/m^2 | Genotonorm |
|---|---|
| Change at Month 12 (n = 39) | 0.52 ± 1.01 |
| Change at Month 24 (n = 39) | 1.30 ± 1.35 |
| Change at Month 36 (n = 27) | 1.89 ± 1.61 |
BA was estimated locally using an X-ray from the left wrist and hand.
| years | Genotonorm |
|---|---|
| Baseline (n = 40) | 8.70 ± 3.28 |
| Change at Month 12 (n = 28) | 1.69 ± 0.90 |
| Change at Month 24 (n = 28) | 2.60 ± 0.97 |
| Change at Month 36 (n = 21) | 4.04 ± 1.09 |
BA was estimated locally using an X-ray from the left wrist and hand. CA at the date of corresponding X-ray (Date of X-ray - Date of birth)/365.25. Ratio of BA/CA at each annual study visit was calculated.
| ratio | Genotonorm |
|---|---|
| Baseline (n = 40) | 0.79 ± 0.15 |
| Month 12 (n = 30) | 0.83 ± 0.15 |
| Month 24 (n = 32) | 0.85 ± 0.12 |
| Month 36 (n = 23) | 0.89 ± 0.14 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Genotonorm | — | 4/46 (8.7%) | 21/46 (45.7%) |
| Event | Genotonorm |
|---|---|
| CryptorchismCongenital, familial and genetic disorders | 1/46 |
| LaryngitisInfections and infestations | 1/46 |
| Staphylococcal infectionInfections and infestations | 1/46 |
| Staphylococcal sepsisInfections and infestations | 1/46 |
| Viral infectionInfections and infestations | 1/46 |
| Head injuryInjury, poisoning and procedural complications | 1/46 |
| Weight decreasedInvestigations | 1/46 |
| Histiocytosis haematophagicNeoplasms benign, malignant and unspecified (incl cysts and polyps) | 1/46 |
| Event | Genotonorm |
|---|---|
| HeadacheNervous system disorders | 5/46 |
| DiarrhoeaGastrointestinal disorders | 2/46 |
| Oral herpesInfections and infestations | 2/46 |
| Bronchopulmonary aspergillosis allergicInfections and infestations | 1/46 |
| InfluenzaInfections and infestations | 1/46 |
| LaryngitisInfections and infestations | 1/46 |
| NasopharyngitisInfections and infestations | 1/46 |
| TracheitisInfections and infestations | 1/46 |
| Joint injuryInjury, poisoning and procedural complications | 1/46 |
| Ligament sprainInjury, poisoning and procedural complications | 1/46 |
| Age Continuous(years) | Genotonorm |
|---|---|
| Mean | 10.3 ± 3.6 |
| Sex: Female, Male(Participants) | Genotonorm |
|---|---|
| Female | 12 |
| Male | 34 |
The record gives a start of Jan 2005, a primary completion of Oct 2011 and a completion of Oct 2011. It does not say whether these dates are actual or estimated.
Results were first posted in Dec 2012, 1 year 2 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Human Growth Hormone